CIDARA THERAPEUTICS, INC. Increase (Decrease) in Other Operating Assets
CIDARA THERAPEUTICS, INC. reported Increase (Decrease) in Other Operating Assets of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2022-03-07
- CIDARA THERAPEUTICS, INC. increase (decrease) in other operating assets for the quarter ending 2019-12-31 was -$801.00K, a 166.20% decline year-over-year.
- CIDARA THERAPEUTICS, INC. increase (decrease) in other operating assets for the quarter ending 2019-09-30 was $456.00K.
- CIDARA THERAPEUTICS, INC. increase (decrease) in other operating assets for the quarter ending 2018-12-31 was $1.21M, a 526.94% increase year-over-year.
- CIDARA THERAPEUTICS, INC. increase (decrease) in other operating assets for the quarter ending 2018-09-30 was -$128.00K.
- CIDARA THERAPEUTICS, INC. increase (decrease) in other operating assets for fiscal 2021 was $0.00.
- CIDARA THERAPEUTICS, INC. increase (decrease) in other operating assets for fiscal 2020 was $0.00.
- CIDARA THERAPEUTICS, INC. increase (decrease) in other operating assets for fiscal 2019 was -$170.00K, a 117.88% decline from fiscal 2018.
- CIDARA THERAPEUTICS, INC. increase (decrease) in other operating assets for fiscal 2018 was $951.00K, a 392.75% increase from fiscal 2017.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-07 | |||
| 2020-12-31 | $0.00 10-K · filed 2022-03-07 | |||
| 2019-12-31 | -$801.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-07 | -$345.00K derived: sum of 2 quarters · filed 2022-03-07 | -$170.00K 10-K · filed 2022-03-07 | |
| 2019-09-30 | $456.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $631.00K 10-Q · filed 2019-11-08 | ||
| 2019-06-30 | $175.00K 10-Q · filed 2019-08-08 | |||
| 2018-12-31 | $1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $1.08M derived: sum of 2 quarters · filed 2021-02-25 | $951.00K 10-K · filed 2021-02-25 | |
| 2018-09-30 | -$128.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -$259.00K 10-Q · filed 2019-11-08 | ||
| 2018-06-30 | -$131.00K 10-Q · filed 2019-08-08 | |||
| 2017-12-31 | $193.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-04 | $193.00K derived: sum of 2 quarters · filed 2020-03-04 | $193.00K 10-K · filed 2020-03-04 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $0.00 10-Q · filed 2018-11-08 | ||
| 2017-06-30 | $0.00 10-Q · filed 2018-08-09 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $0.00 derived: sum of 2 quarters · filed 2019-02-28 | $117.00K 10-K · filed 2019-02-28 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $117.00K 10-Q · filed 2017-11-08 | ||
| 2016-06-30 | $117.00K 10-Q · filed 2017-08-09 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $0.00 10-K · filed 2018-02-27 | ||
| 2015-09-30 | $0.00 10-Q · filed 2016-11-10 | |||
| 2014-12-31 | $96.00K 10-K · filed 2017-03-15 |